COLLECTIONS
WORKFLOWS

Recent Finacing
Recent Raise
Euthymics Bioscience is a clinical-stage neuroscience company developing triple reuptake inhibitors—EB-1010 for major depression and EB-1020 as a non-stimulant adult ADHD therapy—based in Cambridge, MA.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors